{"preliminary_commentary":{"by_channel":{"x_thread":5},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":false},"commentary_summary":null,"drugs_tested":[],"indication":"chemotherapy-sensitive stage II-III nasopharyngeal carcinoma","name":"NCT04448522","nct_id":"NCT04448522","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nct04448522. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"3 cycles of gemcitabin and cisplatin induction chemotherapy plus concurrent cheomtherapy with IMRT dosage of 63.6 Gy","label":"Reduced dosage IMRT group","type":"EXPERIMENTAL"},{"description":"3 cycles of gemcitabin and cisplatin induction chemotherapy plus concurrent cheomtherapy with IMRT dosage of 69.96 Gy","label":"Conventional dosage IMRT group","type":"ACTIVE_COMPARATOR"}],"collaborators":["National Cancer Centre, Singapore","Affiliated Cancer Hospital & Institute of Guangzhou Medical University","Zhongshan People's Hospital, Guangdong, China","Yuebei People's Hospital","Wuzhou Red Cross Hospital"],"completion_date":{"date":"2028-08","type":"ESTIMATED"},"conditions":["Nasopharyngeal Carcinoma","Radiotherapy","Chemotherapy"],"enrollment":{"count":508,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"reduced dosage IMRT","otherNames":[],"type":"RADIATION"},{"name":"conventional dosage IMRT","otherNames":[],"type":"RADIATION"}],"last_update":"2020-09-28","lead_sponsor":"Sun Yat-sen University","official_title":"A Multicenter Randomized Controlled Trial Comparing Reduced Dose With Regular Dose Intensity-modulated Radiotherapy for Chemotherapy Sensitive Stage II-III Nasopharyngeal Carcinoma","overall_status":"RECRUITING","phases":["PHASE3"],"primary_completion_date":{"date":"2026-08","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Progress-free survival (PFS)","timeFrame":"3 years"}],"references":[],"start_date":{"date":"2020-08-18","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma","url":"https://clinicaltrials.gov/study/NCT04448522"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.1","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nct04448522"}